• The company's ‘Never Down’ approach to EV charging presents a trustworthy solution for drivers with industry-leading reliability 
• The 83 chargers will help reliably electrify Boston’s state-of-the-art life sciences campus, home to Pfizer, Novartis, and LabCentral
• The 12 already-installed chargers have contributed to nearly 9,000lbs in CO2 reduction in less than one month

Xeal, the only no-central-network-needed EV charging solution with industry-leading uptime, and an affiliate of the Bulfinch Companies, a leading Boston-based commercial real estate investment, development, and management firm, and Harrison Street, a leading investment management firm exclusively focused on alternative real assets announced the strategic deployment of over 80 advanced EV chargers at Osborn Triangle, a premier life sciences campus in Cambridge’s life science hub Kendall Square. This initiative propels the life science tenants towards sustainable urban development as well as enhancing the city's EV charging infrastructure.

With nearly a third of all U.S. office development dedicated to life science projects, we believe the vitality of this sector hinges on real estate infrastructure that not only meets current demands but also facilitates future expansion. The collaboration between Xeal, Bulfinch, and Harrison Street addresses the immediate and long-term needs of life science tenants and community members. By providing reliable and easily accessible EV charging solutions, the partnership fosters a sustainable, innovative environment that nurtures both the professional endeavors and daily lives of pioneers in life sciences research and development.

“By equipping the campus with reliable EV chargers, we’re helping our tenants reach sustainability goals while making it easier to adopt sustainable transportation," said Robert M. Brierley, SVP, Director of Property Management at Bulfinch. “Osborn Triangle's tenants are driving innovation; we’re making sure they have the charge to do so.” 

Accommodating 650 parking spots, Osborn Triangle stands at the crossroads of innovation and sustainability within Boston's life science CRE landscape. By installing Xeal’s EV chargers at this location, Bulfinch and Harrison Street underscore their commitment to offering sustainable transportation solutions for tenants including Pfizer, Novartis, and LabCentral, along with campus visitors. 

To date, Bulfinch and Harrison Street have installed their first 12 state-of-the-art Level 2 Xeal chargers, with an additional 71 scheduled to deploy in the coming months. In less than one month, these first 12 chargers have already delivered 11,500 electric miles and 8,876 lbs of CO2 reduction, with 100% reliability.

"At Xeal, we recognize the critical role life sciences have in our local communities. We want to ensure that when people need essential fuel, they can depend on Xeal to power their journeys – whether it’s another day working in the lab or charging up at an apartment building overnight,” said Alexander Isaacson, co-founder and CEO at Xeal. “It's about delivering on the expectation of reliability, mirroring the steadfast commitment of the professionals building the latest innovations in healthcare.”

Distinguishing itself from traditional charging systems, Xeal's chargers eliminate the common issue of single-point-of-failure central networks. The source of 95% of charging failures, ranging from 55% connectivity to 40% other central-networked related critical functions such as payment, firmware, and IoT functionality. Xeal utilizes a patented, self-reliant computing protocol ensuring constant availability, thus making its network more dependable than others on the market.

To learn more about how Xeal can improve the charging experience of your medical facility, apartment, or property, visit xealenergy.com